Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Byungsan Choi"'
Autor:
Hongwon Lee, Byungsan Choi, Saem Hong, Yunseo Lee, Hayoung Park, Ja Min Byun, Youngil Koh, Tae-Young Yoon
Publikováno v:
HemaSphere, Vol 7, p e423765d (2023)
Externí odkaz:
https://doaj.org/article/a7008d44e1024db38df201e1e534a82b
Autor:
Jung Won Shin, Soohyun Kim, Suji Ha, Byungsan Choi, Seongyeong Kim, Seock-Ah Im, Tae-Young Yoon, Junho Chung
Publikováno v:
Biomolecules, Vol 9, Iss 10, p 629 (2019)
G309 or S310 mutations on the HER2 extracellular domain II induce receptor activation. Clinically, S310F is most frequent among HER2 extracellular domain mutations and patients with the S310F mutation without HER2 amplification responded to trastuzum
Externí odkaz:
https://doaj.org/article/32bca6a8089448d2a07238e87e65022b
Autor:
Changju Chun, Ja Min Byun, Minkwon Cha, Hongwon Lee, Byungsan Choi, Hyunwoo Kim, Saem Hong, Yunseo Lee, Hayoung Park, Youngil Koh, Tae-Young Yoon
BH3 mimetics are protein-protein interaction (PPI) inhibitors that saturate anti-apoptotic proteins in the BCL2 family to lift the resistance of cancer cells to apoptosis, a prominent example of protein complex-targeting therapies1–4. Despite the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98571212a094217072239a9ec7033ecb
https://doi.org/10.1101/2023.01.16.524337
https://doi.org/10.1101/2023.01.16.524337
Publikováno v:
Journal of the American Chemical Society. 138:14238-14241
Extremely weak protein-protein interactions (PPIs), signified by micromolar or even millimolar dissociation constants, are one of the keys to understanding the rapid responses of cellular systems. Although single-molecule methods are particularly use
Publikováno v:
Journal of the American Chemical Society. 139(30)
Autor:
Seongyeong Kim, Jung Won Shin, Seock-Ah Im, Soohyun Kim, Byungsan Choi, Suji Ha, Tae-Young Yoon, Junho Chung
Publikováno v:
Biomolecules
Biomolecules, Vol 9, Iss 10, p 629 (2019)
Volume 9
Issue 10
Biomolecules, Vol 9, Iss 10, p 629 (2019)
Volume 9
Issue 10
G309 or S310 mutations on the HER2 extracellular domain II induce receptor activation. Clinically, S310F is most frequent among HER2 extracellular domain mutations and patients with the S310F mutation without HER2 amplification responded to trastuzum
Publikováno v:
Journal of the American Chemical Society; 11/2/2016, Vol. 138 Issue 43, p14238-14241, 4p